These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22288563)

  • 1. INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
    Rose AJ; Berlowitz DR; Miller DR; Hylek EM; Ozonoff A; Zhao S; Reisman JI; Ash AS
    J Thromb Haemost; 2012 Apr; 10(4):590-5. PubMed ID: 22288563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation.
    Rose AJ; Ozonoff A; Berlowitz DR; Ash AS; Reisman JI; Hylek EM
    Chest; 2011 Aug; 140(2):359-365. PubMed ID: 21310837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
    Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Regional Effort to Improve Warfarin Management.
    Rose AJ; Park A; Gillespie C; Van Deusen Lukas C; Ozonoff A; Petrakis BA; Reisman JI; Borzecki AM; Benedict AJ; Lukesh WN; Schmoke TJ; Jones EA; Morreale AP; Ourth HL; Schlosser JE; Mayo-Smith MF; Allen AL; Witt DM; Helfrich CD; McCullough MB
    Ann Pharmacother; 2017 May; 51(5):373-379. PubMed ID: 28367699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
    Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH
    J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
    Rose AJ; Hylek EM; Ozonoff A; Ash AS; Reisman JI; Berlowitz DR
    J Thromb Haemost; 2010 Oct; 8(10):2182-91. PubMed ID: 20653840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).
    Rose AJ; Hylek EM; Ozonoff A; Ash AS; Reisman JI; Berlowitz DR
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):22-9. PubMed ID: 21098779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial.
    Matchar DB; Love SR; Jacobson AK; Edson R; Uyeda L; Phibbs CS; Dolor RJ
    J Thromb Thrombolysis; 2015 Jul; 40(1):17-25. PubMed ID: 25209313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways to poor anticoagulation control.
    Razouki Z; Ozonoff A; Zhao S; Rose AJ
    J Thromb Haemost; 2014 May; 12(5):628-34. PubMed ID: 24548552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.
    Van Den Ham HA; Klungel OH; Leufkens HG; Van Staa TP
    J Thromb Haemost; 2013 Jan; 11(1):107-15. PubMed ID: 23088617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of a 12-week INR follow-up protocol over 2 years in an anticoagulation clinic: a single-arm prospective cohort study.
    Porter AL; Margolis AR; Staresinic CE; Nagy MW; Schoen RR; Ray CA; Fletcher CD
    J Thromb Thrombolysis; 2019 Feb; 47(2):200-208. PubMed ID: 30368762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.